Knocking-down ZEB2 (ZEB2-KD) in the mesenchymal-like MDA-MB-231 breast cancer cell line (which expresses more endogenous ZEB2 and less RAB25 than MCF7 cells) induced the expression of RAB25 and CDH1 (Fig. 1b). This evidence concerns the gene ZEB2 and breast cancer.